UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 1.459

Sortiert nach

TBCRC 030: a phase II study of preoperative cisplatin versus paclitaxel in triple-negative breast cancer: evaluating the homologous recombination deficiency (HRD) biomarker

Annals of oncology, 2020-11, Vol.31 (11), p.1518-1525

2020

Volltextzugriff (PDF)

Sacituzumab govitecan in previously treated hormone receptor-positive/HER2-negative metastatic breast cancer: final results from a phase I/II, single-arm, basket trial

Annals of oncology, 2020-12, Vol.31 (12), p.1709-1718

2020

Volltextzugriff (PDF)

Circulating tumor DNA association with residual cancer burden after neoadjuvant chemotherapy in triple-negative breast cancer in TBCRC 030

Annals of oncology, 2023-10, Vol.34 (10), p.899-906

2023

Volltextzugriff (PDF)

1-Year Outcomes of Cardioband Tricuspid Valve Reconstruction System Early Feasibility Study

JACC. Cardiovascular interventions, 2022-10, Vol.15 (19), p.1921-1932

2022

Volltextzugriff (PDF)

Tucatinib, Trastuzumab, and Capecitabine for HER2-Positive Metastatic Breast Cancer

The New England journal of medicine, 2020-02, Vol.382 (7), p.597-609

2020

Volltextzugriff (PDF)

Sacituzumab Govitecan-hziy in Refractory Metastatic Triple-Negative Breast Cancer

The New England journal of medicine, 2019-02, Vol.380 (8), p.741-751

2019

Volltextzugriff (PDF)

Computed tomography‐derived membranous septum length as predictor of conduction abnormalities and permanent pacemaker implantation after TAVI: A meta‐analysis of observational studies

Catheterization and cardiovascular interventions, 2023-06, Vol.101 (7), p.1203-1213

2023

Volltextzugriff (PDF)

Large Obstructive Cardiac Myxofibrosarcoma Is Nearly Invisible on Transthoracic Echocardiogram

Echocardiography (Mount Kisco, N.Y.), 2009-08, Vol.26 (7), p.847-851

2009

Volltextzugriff (PDF)

Impact of coronary artery disease and revascularization on outcomes of transcatheter aortic valve replacement for severe aortic stenosis

Cardiovascular revascularization medicine, 2024-05

2024

Volltextzugriff (PDF)

Combining Adjuvant Radiotherapy with Capecitabine Appears to Be Safe and Feasible for Chemotherapy-Resistant Breast Cancer

International journal of radiation oncology, biology, physics, 2019-09, Vol.105 (1), p.E33-E34

2019

Volltextzugriff (PDF)

333P Evaluation of a composite PET/CT and HER2 tissue-based biomarker to predict response to neoadjuvant HER2-directed therapy in early breast cancer (TBCRC026)

Annals of oncology, 2023-10, Vol.34, p.S316-S316

2023

Volltextzugriff (PDF)

Pulmonary hypertension predicts mortality and morbidity in patients with dilated cardiomyopathy

Annals of internal medicine, 1992-06, Vol.116 (11), p.888

1992

Volltextzugriff (PDF)

Abstract OT2-07-08: Withdrawn

Cancer research (Chicago, Ill.), 2019-02, Vol.79 (4_Supplement), p.OT2-07-08-OT2-07-08

2019

Volltextzugriff (PDF)

191P Correlation of early change in standardized uptake value (SUV) on positron emission tomography (PET/CT) with recurrence-free survival (RFS) and overall survival (OS) in patients with primary operable HER2-positive breast cancer (TBCRC026)

Annals of oncology, 2022-09, Vol.33, p.S623-S624

2022

Volltextzugriff (PDF)

565TiP A phase I/II dose-escalation and expansion study of ZN-c5, an oral selective estrogen receptor degrader (SERD), as monotherapy and in combination with palbociclib in patients with advanced estrogen receptor (ER)+/HER2- breast cancer

Annals of oncology, 2021-09, Vol.32, p.S619-S619

2021

Volltextzugriff (PDF)

Effect of left ventricular hypertrophy and its regression on ventricular electrophysiology and vulnerability to inducible arrhythmia in the feline heart

Circulation (New York, N.Y.), 1995-01, Vol.91 (2), p.426-430

1995

Volltextzugriff (PDF)

Russian underwater tunnels in the system of international transportation ways

Tunnelling and underground space technology, 2005-11, Vol.20 (6), p.595-599

2005

Volltextzugriff (PDF)

TBCRC 030: A phase II study of preoperative cisplatin vs. paclitaxel in triple-negative breast cancer: evaluating the homologous recombination deficiency (HRD) biomarker

Annals of oncology, 2020-08, Vol.31 (11), p.1518-1525

2020

Volltextzugriff (PDF)

Abstract OT3-04-04: A randomized phase II study of pembrolizumab in combination with carboplatin versus carboplatin alone in breast cancer patients with chest wall disease, with immunologic and genomic correlative studies

Cancer research (Chicago, Ill.), 2019-02, Vol.79 (4_Supplement), p.OT3-04-04-OT3-04-04

2019

Volltextzugriff (PDF)

Initial results of a phase 1 dose expansion cohort of M6620 (formerly VX-970), an ATR inhibitor, in combination with cisplatin in patients with advanced triple-negative breast cancer NCT02157792

Annals of oncology, 2017-09, Vol.28, p.v76-v76

2017

Volltextzugriff (PDF)

Abstract OT1-02-03: TBCRC 044: A randomized phase II study of pembrolizumab in combination with carboplatin versus carboplatin alone in breast cancer patients with chest wall disease

Cancer research (Chicago, Ill.), 2018-02, Vol.78 (4_Supplement), p.OT1-02-03-OT1-02-03

2018

Volltextzugriff (PDF)

Abstract OT2-07-07: ATR inhibitor M6620 (formerly VX-970) with cisplatin in metastatic triple-negative breast cancer: Preliminary results from a phase 1 dose expansion cohort (NCT02157792)

Cancer research (Chicago, Ill.), 2018-02, Vol.78 (4_Supplement), p.OT2-07-07-OT2-07-07

2018

Volltextzugriff (PDF)

Abstract P2-11-01: Safety and efficacy of sacituzumab govitecan (anti-Trop-2-SN-38 antibody-drug conjugate) as ≥3rd-line therapeutic option for treatment-refractory HER2-negative metastatic breast cancer (HER2Neg mBC)

Cancer research (Chicago, Ill.), 2019-02, Vol.79 (4_Supplement), p.P2-P2-11-01

2019

Volltextzugriff (PDF)

Abstract OT3-02-02: ENDEAR: A randomized international phase 3 study comparing the efficacy and safety of enzalutamide in combination with paclitaxel chemotherapy or as monotherapy vs placebo with paclitaxel in patients with advanced diagnostic-positive triple-negative breast cancer

Cancer research (Chicago, Ill.), 2017-02, Vol.77 (4_Supplement), p.OT3-02-02-OT3-02-02

2017

Volltextzugriff (PDF)

1 – 25 von 1.459

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(897)
Mit Volltextzugriff
(1.387)

Publikationsform

4 weitere anzeigen...

Weniger anzeigen...

Sprache

Englisch
(1.447)
Japanisch
(62)
Russisch
(11)
Französisch
(1)
Deutsch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(740)
Technology
(470)
Computer Science
(463)
Computer Science, Theory & Methods
(455)
Computer Science, Interdisciplinary Applications
(444)
Computer Science, Software Engineering
(442)
Life Sciences & Biomedicine
(252)
Humans
(216)
Female
(130)
Male
(122)
Biological And Medical Sciences
(93)
Medical Sciences
(85)
Adult
(76)
Middle Aged
(74)
Aged
(55)
Child
(51)
Animals
(46)
Adolescent
(40)
Risk Factors
(38)
Oncology
(33)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(5)

Menü

Weitere Dienste

Einstellungen

TBCRC 030: a phase II study of preoperative cisplatin versus paclitaxel in triple-negative breast cancer: evaluating the homologous recombination deficiency (HRD) biomarker

Sacituzumab govitecan in previously treated hormone receptor-positive/HER2-negative metastatic breast cancer: final results from a phase I/II, single-arm, basket trial

Circulating tumor DNA association with residual cancer burden after neoadjuvant chemotherapy in triple-negative breast cancer in TBCRC 030

1-Year Outcomes of Cardioband Tricuspid Valve Reconstruction System Early Feasibility Study

Tucatinib, Trastuzumab, and Capecitabine for HER2-Positive Metastatic Breast Cancer

Sacituzumab Govitecan-hziy in Refractory Metastatic Triple-Negative Breast Cancer

Computed tomography‐derived membranous septum length as predictor of conduction abnormalities and permanent pacemaker implantation after TAVI: A meta‐analysis of observational studies

Large Obstructive Cardiac Myxofibrosarcoma Is Nearly Invisible on Transthoracic Echocardiogram

Impact of coronary artery disease and revascularization on outcomes of transcatheter aortic valve replacement for severe aortic stenosis

Genomic profiling of ER + breast cancers after short-term estrogen suppression reveals alterations associated with endocrine resistance

Combining Adjuvant Radiotherapy with Capecitabine Appears to Be Safe and Feasible for Chemotherapy-Resistant Breast Cancer

333P Evaluation of a composite PET/CT and HER2 tissue-based biomarker to predict response to neoadjuvant HER2-directed therapy in early breast cancer (TBCRC026)

Pulmonary hypertension predicts mortality and morbidity in patients with dilated cardiomyopathy

Abstract OT2-07-08: Withdrawn

191P Correlation of early change in standardized uptake value (SUV) on positron emission tomography (PET/CT) with recurrence-free survival (RFS) and overall survival (OS) in patients with primary operable HER2-positive breast cancer (TBCRC026)

565TiP A phase I/II dose-escalation and expansion study of ZN-c5, an oral selective estrogen receptor degrader (SERD), as monotherapy and in combination with palbociclib in patients with advanced estrogen receptor (ER)+/HER2- breast cancer

Effect of left ventricular hypertrophy and its regression on ventricular electrophysiology and vulnerability to inducible arrhythmia in the feline heart

Russian underwater tunnels in the system of international transportation ways

TBCRC 030: A phase II study of preoperative cisplatin vs. paclitaxel in triple-negative breast cancer: evaluating the homologous recombination deficiency (HRD) biomarker

Abstract OT3-04-04: A randomized phase II study of pembrolizumab in combination with carboplatin versus carboplatin alone in breast cancer patients with chest wall disease, with immunologic and genomic correlative studies

Initial results of a phase 1 dose expansion cohort of M6620 (formerly VX-970), an ATR inhibitor, in combination with cisplatin in patients with advanced triple-negative breast cancer NCT02157792

Abstract OT1-02-03: TBCRC 044: A randomized phase II study of pembrolizumab in combination with carboplatin versus carboplatin alone in breast cancer patients with chest wall disease

Abstract OT2-07-07: ATR inhibitor M6620 (formerly VX-970) with cisplatin in metastatic triple-negative breast cancer: Preliminary results from a phase 1 dose expansion cohort (NCT02157792)

Abstract P2-11-01: Safety and efficacy of sacituzumab govitecan (anti-Trop-2-SN-38 antibody-drug conjugate) as ≥3rd-line therapeutic option for treatment-refractory HER2-negative metastatic breast cancer (HER2Neg mBC)

Abstract OT3-02-02: ENDEAR: A randomized international phase 3 study comparing the efficacy and safety of enzalutamide in combination with paclitaxel chemotherapy or as monotherapy vs placebo with paclitaxel in patients with advanced diagnostic-positive triple-negative breast cancer

Suchergebnisse filtern